196 results on '"Jürgenliemk-Schulz, I.M."'
Search Results
2. Vaginal changes, sexual functioning and distress of women with locally advanced cervical cancer treated in the EMBRACE vaginal morbidity substudy
3. Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials
4. Impact of transitioning to an online course – A report from the ESTRO gyn teaching course
5. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging – An analysis from the EMBRACE study
6. Radiotherapie bij gynaecologische tumoren
7. OC-0508 Molecular classification of endometrial cancer is predictive of response to adjuvant radiotherapy
8. OC-0605 Patient-reported peripheral neuropathy in cervix cancer patients: a trajectory analysis
9. MO-0060 prognostic impact of waiting time between diagnosis and treatment in patients with cervical cancer.
10. Multi-modal Volumetric Concept Activation to Explain Detection and Classification of Metastatic Prostate Cancer on PSMA-PET/CT
11. Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer
12. Fertility-sparing surgery and fertility preservation in cervical cancer: The desire for parenthood, reproductive and obstetric outcomes
13. OC-0296 Risk factors for severe gastrointestinal morbidity in locally advanced cervix cancer (EMBRACE study)
14. Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer
15. OC-0606 Severity and time-weighted gastrointestinal morbidity in cervix cancer: EMBRACE analysis with MOSES
16. OC-0569: Incidence of severe gastrointestinal and urinary fistulas, bleeding and strictures: EMBRACE results
17. OC-1049: Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer
18. PO-1868: In silico hypofractionation feasibility study for lymph node oligometastases SBRT on the MRI-linac
19. OC-1047: Dose to vaginal wall in cervical cancer brachytherapy and associated morbidity
20. PH-0404: Risk factors for late diarrhoea after radio(chemo)therapy in cervical cancer: EMBRACE I results
21. PD-0672: Effect of a vacuum mattress on bone & target intra-fraction motion during MR-guided lymph node SBRT
22. OC-0369: Long-Term Quality of Life after (chemo)radiotherapy for high-risk Endometrial Cancer in PORTEC-3
23. PO-1612: Bladder filling during MR-linac treatment sessions.
24. EP-2006 Dosimetric benefit of the first clinical SBRT of lymph node oligometastases on the 1.5T MR-linac
25. EP-1624 First clinical experiences with SBRT on the 1.5 T MR-linac for pelvic lymph node oligometastases
26. OC-0172 Performance of ring vs ovoids and intracavitary vs intracavitary-interstitial in the EMBRACE study
27. PV-0368 Persistence of late substantial patient reported symptoms (LAPERS): A report from the EMBRACE study
28. OC-0506 Patient-reported sexual outcomes after definitive RCHT+IGABT for cervical cancer (EMBRACE study)
29. Implementatie en quality assurance van state-of-the-art radiotherapie voor gevorderd cervixcarcinoom in Nederland: een kwaliteitsbevorderingsproject
30. OC-0392: Impact of image-guided brachytherapy on pattern of relapse in the RetroEMBRACE cervical cancer study
31. PO-0863: “First in Man” treatments with the MRI-linac provide clinical proof of the concept
32. EP-1790: Patient specific quality assurance on the MRI Linac for the First-in-Man study
33. OC-0323: Patterns of recurrence in the randomised PORTEC-3 trial of chemoradiotherapy for endometrial cancer
34. OC-0616: 1.5T MRI-Linac treatment planning for multiple lymph node oligometastases in the pelvic area
35. OC-0055: Local failures after radiochemotherapy and MR-image-guided brachytherapy in cervical cancer patients
36. OC-0056: Bowel morbidity in cervix cancer after RCHT+IGABT; physician and patient reported outcome - EMBRACE
37. OC-0052: Physician assessed and patient reported bladder morbidity after RCHT and IGABT for cervical cancer
38. PO-0905: (Semi-)Automatic contouring strategies for rectal boost treatment on the MR-Linac
39. OC-0051: Fatigue, insomnia, hot flashes (CTCAE) after definitive RCHT+IGABT for cervical cancer (EMBRACE)
40. Importance of Technique, Dose Prescription, and Contouring in Cervix External Beam Radiation Therapy: Current and Future Practice in a Large Multicenter Study (EMBRACE)
41. Nodal Failure After Chemoradiation and Magnetic Resonance Imaging Guided Adaptive BT in Cervical Cancer: A Subanalysis Within Embrace
42. Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Combined External Beam Radiotherapy, Image-Guided Adaptive Brachytherapy (IGABT) and Concomitant Chemotherapy; a Descriptive Analysis from the Embrace Study
43. SP-0421: Brachytherapy pelvic and MRI-Linac combination
44. OC-0486: Nodal failure after (chemo-)radiation and MRI guided adaptive BT in cervical cancer: a sub-analysis within EMBRACE
45. PD-0436: Long-term bowel and bladder symptoms after pelvic radiotherapy or vaginal brachytherapy in the PORTEC-2 trial
46. L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
47. PO-0708: Patterns of Care in the Netherlands for Radiotherapy of Women with Locally Advanced Cervical Cancer
48. Second Cancers in Patients Treated With Surgery and Radiation Therapy for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials
49. EP-1719: MRI-based contour propagation for adaptive cervical cancer radiotherapy: The added value of dosimetric analysis
50. OC-0263: Brachytherapy vaginal dose de-escalation in locally advanced cervical cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.